[Stryker]

Originally Posted by kccrow

Hard to say, I'll give you the long answer to say not really.

OTC and Spotrac have his contract f'd up right now I think. According to the original reports, he shaved money off the deal but that's not what either site is showing.

His contract was supposed to be converted to a 2-year, $29 million deal with up to $7 million in incentives that could make it worth $36 million. As well, he is supposed to make $1.2 million more than the cap savings that were to be realized.

IIRC, he would have saved 12.7 million in a cut, which means he should be on the cap at 13.9 this year. They have 13.7, so horse a piece on this year in terms of real dollars. Next year is what is ****ed for sure because they have him at $28.675 million. Salary is also rolled into bonus money over the two years as part of their numbers, which is unlikely to have happened.

If the bonus part is correct, then next year's salary figure should be $5,725,000 and makes both years of the contract have negative cap implications if he is cut (I find that unlikely).

The incentives of $7 million, whether spread over both years or not, make me "think" they are wrong on the prorated bonus spread too.

All told, it's really hard to figure out what the implications are until his contract numbers are actually corrected. I would have to guess that trading him this year will absolutely have a negative cap effect, which means that probably isn't on the table either way.

Thanks as always KCCROW - I guess I was trying to think outside the box.